Hi
Hi
Hi
United States and prescribed to patients when diagnosed with treatment-resistant nodular and
cystic acne vulgaris (1). It functions by altering DNA transcription, affecting different stages of
the cycle such as differentiation and apoptosis, resulting in decreased size and production of
sebaceous glands and becoming an effective inhibitor of sebum secretion. (2, 3) This medication
is beneficial in treating and preventing the recurrence of resistant nodular and cystic acne, with a
success rate of approximately 90% (3). However, there is a widespread recognition that many
medicines have effects, some favorable and some of which are critical. According to a recent
review, 3.4% of patients taking Isotretinoin experienced ophthalmologic side effects. (4)
One of its reported side effects is myopia, an eye disorder that enables visual images to focus in
front of the retina, affecting the vision of distant objects. Early research did not clearly describe
the association of myopia in patients treated with Isoretinoin. However, a study highlighted that
in the degeneration of the cornea, making it a primary factor contributing to the development of
myopia. (3) According to a clinical trial on male acne patients given retinoids, such as
Isoretinoin, the development of the sclera and the differentiation of fibroblast into myofibroblast
are both impacted by a decrease in Transforming growth factor-beta (TGF-B), which occurs as
(WHO) received 1741 out of approximately 2300 events with Ocular Adverse Events sporadic
reports of possible ocular adverse events associated with Isotretinoin. Out of approximately 2300
events with Ocular Adverse Events, 3.57% reported refractive change(1). Notably, short-
sightedness is the most common type of refractive error. (1) Furthermore, in a 2020 pilot study,
patients with acne vulgaris were treated with Isotretinoin, while the rest were healthy controls.
The results concluded that Isotretinoin consumption for six months resulted in increased myopia
and axial length (2) Moreover, a female patient in her late 20s underwent laser-assisted in situ
nearsightedness and blurred vision after being prescribed oral Isotretinoin therapy daily to treat
her chronic inflammatory acne vulgaris. (3). Similarly, while on oral Isotretinoin therapy for
acne , a 28-year-old woman also presented with a rare case of elevated intraocular pressure (IOP)
with transient bilateral angle closure and the myopic shift. However, IOP returned to normal two
weeks after ceasing oral Isotretinoin. (4) Lastly, a patient in his early 20’s was presented with
nodulocystic acne with a history of 10 years of stable myopia. He was prescribed 0.3 mg/kg oral
Isotretinoin for his acne. After two weeks, the patient began to notice blurred vision, which
worsened over time, and his myopia increased in both eyes (6).
Surprisingly, despite complications of myopia, the technical brochure of Isotretinoin does not
mention the ocular side effect of this drug which makes it difficult for an early diagnosis (3). Due
to this, the ophthalmologists and the dermatologists are unaware of this side effect and fail to
take a comprehensive history of previous eye complaints before prescribing this drug.
Considering this, it is important to prevent patients from developing extreme myopia. To cater to
this problem, public policies and therapies must be developed. For instance, dermatologists
should only prescribe oral therapy of Isotretinoin when required and confirm any past surgical
Isotretinoin oral therapy. If a patient experiences ocular issues following oral Isotretinoin
treatment, a consultation should be considered necessary as it would help with an early diagnosis
1. Fraunfelder FT, Fraunfelder FW, Edwards R. Ocular side effects possibly associated with
4. Park YM, Lee TE. Isotretinoin-induced Angle Closure and Myopic Shift. J Glaucoma.
2017;26(11):e252-e4.
2022;101(30):e29961.
7. Pan CW, Ramamurthy D, Saw SM. Worldwide prevalence and risk factors for myopia.
22150586.